Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cipepofol TCI Model Validation in General Anesthesia
NCT06740201Phase 4Recruiting
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Start
- Jan 2025
- Primary completion
- Mar 2025
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 4 trial of cipepofol in general anesthesia, sponsored by Haisco Pharmaceutical Group Co., Ltd.. Started Jan 2025; status: recruiting.
02
Drugs
cipepofol
03
Conditions
general anesthesia
Beyond the preview
Go deeper on NCT06740201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06740201.